市場調査レポート
商品コード
1291591

一般用医薬品(OTC)市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Over The Counter (OTC) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
一般用医薬品(OTC)市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の一般用医薬品(OTC)医薬品市場規模は、2022年に1,588億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.24%の成長率(CAGR)を示し、2028年までに2,317億米ドルに達すると予想しています。

一般用医薬品(OTC)医薬品は、非処方箋薬としても知られており、処方箋やヘルスケア専門家による治療を受ける必要なく使用することができます。OTC医薬品は安全で効果的であり、疼痛、咳や風邪、下痢、便秘、にきび、繰り返す片頭痛やアレルギーの治療に役立ちます。現在、世界中の薬局、コンビニエンスストア、スーパーマーケット、ガソリンスタンドで購入することができます。

一般用医薬品(OTC)医薬品の市場動向:

軽度の疾病を治療するためにOTC医薬品を利用する人が増えていることは、市場の成長を促進する重要な要因の一つです。また、制酸剤、ヒスタミン2(H2)ブロッカー、プロトンポンプ阻害剤(PPI)などの一般用医薬品は、胸焼けや消化不良を緩和・予防するために使用されています。また、コロナウイルス感染症(COVID-19)の発生により、セルフケアの重要性に対する個人の意識が高まっています。このことが、栄養補助食品の売上を増加させ、市場の成長を強めています。さらに、主要企業は、消費者層を拡大し、地理的な存在感を高めるために、製品ポートフォリオを拡大しています。これは、規制当局による処方薬のOTC薬への切り替え認可の増加と相まって、市場にプラスの影響を及ぼしています。これとは別に、現在、ヘルスケア費用の増加を理由に、医師に相談せずにOTC医薬品を選択する人が増えています。さらに、セルフメディケーションの実践は、慢性疾患のコントロール、欠勤の減少、軽症時の医療資源の枯渇を防ぐことに役立ちます。その他、世界の老人人口の増加、流通チャネルの急速な拡大、製薬業界の著しい成長などが、全体の売上と収益性を押し上げています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 一般用医薬品(OTC)の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 製品タイプ別市場内訳

  • 咳・風邪・インフルエンザ対策製品
    • 市場動向
    • 市場予測
  • 鎮痛剤
    • 市場動向
    • 市場予測
  • 皮膚科製品
    • 市場動向
    • 市場予測
  • 消化器関連製品
    • 市場動向
    • 市場予測
  • ビタミン、ミネラル、サプリメント(VMS)
    • 市場動向
    • 市場予測
  • 減量・ダイエット製品
    • 市場動向
    • 市場予測
  • 眼科用製品
    • 市場動向
    • 市場予測
  • 睡眠補助薬
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 投与経路別市場内訳

  • 経口剤
    • 市場動向
    • 市場予測
  • 非経口剤
    • 市場動向
    • 市場予測
  • 外用剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 剤形別市場内訳

  • 錠剤、カプセル剤
    • 市場動向
    • 市場予測
  • 液状
    • 市場動向
    • 市場予測
  • 軟膏剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 流通チャネル別市場内訳

  • 病院内薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
図表

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2022
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2022
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2022
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players
目次
Product Code: SR112023A5189

The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global over the counter (OTC) drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, route of administration, dosage form and distribution channel.

Breakup by Product Type:

Cough, Cold and Flu Products

Analgesics

Dermatology Products

Gastrointestinal Products

Vitamins, Minerals and Supplements (VMS)

Weight-loss/Dietary Products

Ophthalmic Products

Sleeping Aids

Others

Breakup by Route of Administration:

Oral

Parenteral

Topical

Others

Breakup by Dosage Form:

Tablets and Capsules

Liquids

Ointments

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global over the counter (OTC) drugs market in 2022?

2. What is the expected growth rate of the global over the counter (OTC) drugs market during 2023-2028?

3. What are the key factors driving the global over the counter (OTC) drugs market?

4. What has been the impact of COVID-19 on the global over the counter (OTC) drugs market?

5. What is the breakup of the global over the counter (OTC) drugs market based on the product type?

6. What is the breakup of the global over the counter (OTC) drugs market based on the route of administration?

7. What is the breakup of the global over the counter (OTC) drugs market based on the dosage form?

8. What is the breakup of the global over the counter (OTC) drugs market based on the distribution channel?

9. What are the key regions in the global over the counter (OTC) drugs market?

10. Who are the key players/companies in the global over the counter (OTC) drugs market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Over The Counter (OTC) Drugs Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product Type

  • 6.1  Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9  Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7   Market Breakup by Route of Administration

  • 7.1  Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Dosage Form

  • 8.1  Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9   Market Breakup by Distribution Channel

  • 9.1  Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3  Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4  Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11  Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12  Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13  Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14  Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis